More on GILD
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $136.30 |
|
|||
| Open | $137.61 | ||||
| 52 Wk High | $108.63 | ||||
| 52 Wk Low | $71.39 | ||||
| Day High | $140.61 | ||||
| Day Low | $134.09 | ||||
| P/E | 74.19 | ||||
| EPS | $1.81 | ||||
| Volume | 6,902,332 | ||||
- Form 4 GILEAD SCIENCES, INC. For: Jul 15 Filed by: Dickinson Andrew D
- Form 4 GILEAD SCIENCES, INC. For: Jul 15 Filed by: Mercier Johanna
- Form 144 GILEAD SCIENCES, INC. Filed by: Mercier Johanna
- Form 144 GILEAD SCIENCES, INC. Filed by: Dickinson Andrew D
- Gilead Sciences (GILD) PT Lowered to $166 at Morgan Stanley
- Gilead Sciences (GILD) PT Lowered to $120 at RBC Capital
- Gilead Sciences (GILD) PT Lowered to $156 at Truist Securities
- HSBC Upgrades Gilead Sciences (GILD) to Buy
- Form 4 GILEAD SCIENCES, INC. For: Jul 01 Filed by: O'Day Daniel Patrick
- FDA clears Gilead's Trodelvy for first-line metastatic TNBC
Entities mentioned with GILD
- Twitter | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- ARK | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Options | View Related Stories »
- Show More...
